George Clark - Jan 10, 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
VP, Chief Accounting Officer
Signature
/s/ George Clark
Stock symbol
BHVN
Transactions as of
Jan 10, 2022
Transactions value $
-$59,796
Form type
4
Date filed
1/12/2022, 08:12 PM
Previous filing
Jan 7, 2022
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $0 +1K +10.89% $0.00 10.2K Jan 10, 2022 Direct
transaction BHVN Common Shares Tax liability -$59.8K -464 -4.56% $128.87* 9.72K Jan 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Options Exercise $0 -1K -50% $0.00 1K Jan 10, 2022 Common Shares 1K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2 Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F3 The reporting person was granted 4,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date.
F4 Not applicable.